Innate Pharma
IPHA
#8408
Rank
A$0.26 B
Marketcap
$3.03
Share price
-4.19%
Change (1 day)
-20.47%
Change (1 year)

EPS for Innate Pharma (IPHA)

EPS in 2022: -$1.29

According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -$1.29. In 2022 the company made an earnings per share (EPS) of -$1.29 a decrease over its 2021 EPS that were of -$1.24.

EPS history for Innate Pharma from 2005 to 2022

Annual EPS

Year EPS Change
2022-$1.294.6%
2021-$1.24-24.98%
2020-$1.65186.89%
2019-$0.57-707.12%
2018$0.09461-105.35%
2017-$1.77-541.28%
2016$0.40-270.34%
2015-$0.24-70.03%
2014-$0.78390.66%
2013-$0.16-8.65%
2012-$0.18-57.03%
2011-$0.41-48.58%
2010-$0.79-40.32%
2009-$1.3324.76%
2008-$1.0622.34%
2007-$0.8716.95%
2006-$0.74-7.23%
2005-$0.80